Van Leeuwen PA - Search Results

1

Cosmetic outcome of breast conserving therapy after sentinel node biopsy versus axillary lymph node dissection.

Fabry HF, Zonderhuis BM, Meijer S, Berkhof J, Van Leeuwen PA, Van der Sijp JR. Fabry HF, et al. Among authors: van leeuwen pa, van der sijp jr. Breast Cancer Res Treat. 2005 Jul;92(2):157-62. doi: 10.1007/s10549-005-0321-z. Breast Cancer Res Treat. 2005. PMID: 15986125

2

Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results.

Vuylsteke RJ, van Leeuwen PA, Statius Muller MG, Gietema HA, Kragt DR, Meijer S. Vuylsteke RJ, et al. Among authors: van leeuwen pa. J Clin Oncol. 2003 Mar 15;21(6):1057-65. doi: 10.1200/JCO.2003.07.170. J Clin Oncol. 2003. PMID: 12637471

3

Sentinel lymph node investigation in melanoma: detailed analysis of the yield from step sectioning and immunohistochemistry.

Gietema HA, Vuylsteke RJ, de Jonge IA, van Leeuwen PA, Molenkamp BG, van der Sijp JR, Meijer S, van Diest PJ. Gietema HA, et al. Among authors: van diest pj, van leeuwen pa, van der sijp jr. J Clin Pathol. 2004 Jun;57(6):618-20. doi: 10.1136/jcp.2003.011742. J Clin Pathol. 2004. PMID: 15166267 Free PMC article.

4

Clinical relevance of parasternal uptake in sentinel node procedure for breast cancer.

Fabry HF, Mutsaers PG, Meijer S, Torrenga H, Pijpers R, Van Leeuwen PA, Van der Sijp JR. Fabry HF, et al. Among authors: van leeuwen pa, van der sijp jr. J Surg Oncol. 2004 Jul 15;87(1):13-8. doi: 10.1002/jso.20073. J Surg Oncol. 2004. PMID: 15221914

5

Sentinel lymph node tumor load: an independent predictor of additional lymph node involvement and survival in melanoma.

Vuylsteke RJ, Borgstein PJ, van Leeuwen PA, Gietema HA, Molenkamp BG, Statius Muller MG, van Diest PJ, van der Sijp JR, Meijer S. Vuylsteke RJ, et al. Among authors: van diest pj, van leeuwen pa, van der sijp jr. Ann Surg Oncol. 2005 Jun;12(6):440-8. doi: 10.1245/ASO.2005.06.013. Epub 2005 Apr 19. Ann Surg Oncol. 2005. PMID: 15864481

6

The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.

Statius Muller MG, van Leeuwen PA, de Lange-De Klerk ES, van Diest PJ, Pijpers R, Ferwerda CC, Vuylsteke RJ, Meijer S. Statius Muller MG, et al. Among authors: van diest pj, van leeuwen pa. Cancer. 2001 Jun 15;91(12):2401-8. Cancer. 2001. PMID: 11413531

7

Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients.

Statius Muller MG, van Leeuwen PA, van Diest PJ, Pijpers R, Nijveldt RJ, Vuylsteke RJ, Meijer S. Statius Muller MG, et al. Among authors: van diest pj, van leeuwen pa. World J Surg. 2002 Dec;26(12):1405-11. doi: 10.1007/s00268-002-6197-8. Epub 2002 Sep 26. World J Surg. 2002. PMID: 12297910

8

Local administration of granulocyte/macrophage colony-stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early-stage melanoma.

Vuylsteke RJ, Molenkamp BG, Gietema HA, van Leeuwen PA, Wijnands PG, Vos W, van Diest PJ, Scheper RJ, Meijer S, de Gruijl TD. Vuylsteke RJ, et al. Among authors: van diest pj, van leeuwen pa. Cancer Res. 2004 Nov 15;64(22):8456-60. doi: 10.1158/0008-5472.CAN-03-3251. Cancer Res. 2004. PMID: 15548718 Clinical Trial.

9

Tumor-specific CD8+ T cell reactivity in the sentinel lymph node of GM-CSF-treated stage I melanoma patients is associated with high myeloid dendritic cell content.

Vuylsteke RJ, Molenkamp BG, van Leeuwen PA, Meijer S, Wijnands PG, Haanen JB, Scheper RJ, de Gruijl TD. Vuylsteke RJ, et al. Among authors: van leeuwen pa. Clin Cancer Res. 2006 May 1;12(9):2826-33. doi: 10.1158/1078-0432.CCR-05-2431. Clin Cancer Res. 2006. PMID: 16675577 Clinical Trial.

10

Intradermal CpG-B activates both plasmacytoid and myeloid dendritic cells in the sentinel lymph node of melanoma patients.

Molenkamp BG, van Leeuwen PA, Meijer S, Sluijter BJ, Wijnands PG, Baars A, van den Eertwegh AJ, Scheper RJ, de Gruijl TD. Molenkamp BG, et al. Among authors: van den eertwegh aj, van leeuwen pa. Clin Cancer Res. 2007 May 15;13(10):2961-9. doi: 10.1158/1078-0432.CCR-07-0050. Clin Cancer Res. 2007. PMID: 17504997 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters